UNH vs BSX
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Boston Scientific Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | BSX |
|---|---|---|
| Price | $405.59 | $51.42 |
| Market cap | $364.06B | $74.52B |
| P/E ratio | 26.0 | 20.7 |
| ROE | 14.15% | 15.34% |
| Profit margin | 3.14% | 17.50% |
| Revenue growth | 0.40% | 7.50% |
| Dividend yield | 2.29% | — |
| Beta | 0.63 | 0.57 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs BSX in plain English
- UNH is the bigger company — about 4.9× the market cap of BSX.
- BSX is cheaper on earnings (P/E 20.7 vs 26.0).
- BSX earns a higher return on equity (15% vs 14%).
- BSX is growing revenue faster (8% vs 0%).
- UNH pays a dividend (2.29%) while the other effectively doesn't.
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
BSX return calculator
See what $1,000 in Boston Scientific Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.